{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:05:03Z","timestamp":1784642703096,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To evaluate the CT and MRI features of pancreatic acinar cell carcinoma (pACC) and their association with patient outcome and survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective single-center study included 49 patients with pathology-proven pancreatic acinar cell carcinoma who underwent diagnostic imaging between August 1998 - September 2019. Two radiologists reviewed CT and MRI features independently. Survival was estimated using the Kaplan-Meier method, and Cox proportional-hazards regression model was used to identify factors associated with survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>pACC tended to present as a solid (31\/49, 63.3%) pancreatic head mass (26\/49, 53.1%) with ill-defined margins (32\/49, 65.3%) and median maximal diameter of 4.1\u00a0cm (IQR, 2.9\u20136.2). Majority of lesions were hypo- or isodense (38\/49, 77.6%) compared to normal pancreatic parenchyma, with heterogenous (39\/49, 79.6%) enhancement pattern. Biliary ductal dilatation was uncommon, with pancreatic ductal dilatation in 22.4% (11\/49) and common bile duct dilatation in 14.3% (7\/49). Intralesional calcifications were seen in 6.1% (3\/49). Metastasis was present in 71.4% (35\/49) of patients at the time of diagnosis. On MRI, 88.9% (16\/18) demonstrated diffusion restriction and 59.1% (13\/22) with heterogenous enhancement. On multivariate analysis, the imaging presence of T1 hyperintensity (<jats:italic>p<\/jats:italic>\u2009=\u20090.02), hypoattenuating necrotic components (<jats:italic>p<\/jats:italic>\u2009=\u20090.02), and splenic vein invasion (<jats:italic>p<\/jats:italic>\u2009=\u20090.04) were associated with worse survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Pancreatic acinar cell carcinoma is a rare pancreatic neoplasm that often presents as a large ill-defined heterogeneously enhancing mass without biliary ductal dilation. T1 hyperintensity, presence of hypoattenuating necrotic components, and splenic vein invasion were independent predictors of survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40644-025-00859-z","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T18:33:21Z","timestamp":1742582001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acinar cell carcinoma of the pancreas: can CT and MR features predict survival?"],"prefix":"10.1186","volume":"25","author":[{"given":"Monica","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Consul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Fernandez-","family":"del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Hernandez-Barco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Kambadakone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"859_CR1","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.3748\/wjg.v28.i40.5827","volume":"28","author":"LF Calimano-Ramirez","year":"2022","unstructured":"Calimano-Ramirez LF, Daoud T, Gopireddy DR, et al. Pancreatic acinar cell carcinoma: A comprehensive review. World J Gastroenterol. 2022;28:5827\u201344.","journal-title":"World J Gastroenterol"},{"key":"859_CR2","doi-asserted-by":"crossref","first-page":"e0243164","DOI":"10.1371\/journal.pone.0243164","volume":"15","author":"N Duorui","year":"2020","unstructured":"Duorui N, Shi B, Zhang T, et al. The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study. PLoS ONE. 2020;15:e0243164.","journal-title":"PLoS ONE"},{"key":"859_CR3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.semdp.2019.07.001","volume":"36","author":"OC Taskin","year":"2019","unstructured":"Taskin OC, Adsay V. Lipase hypersecretion syndrome: A distinct form of paraneoplastic syndrome specific to pancreatic acinar carcinomas. Semin Diagn Pathol. 2019;36:240\u20135.","journal-title":"Semin Diagn Pathol"},{"key":"859_CR4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00261-017-1330-1","volume":"43","author":"NS Gandhi","year":"2018","unstructured":"Gandhi NS, Feldman MK, Le O, Morris-Stiff G. Imaging mimics of pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2018;43:273\u201384.","journal-title":"Abdom Radiol (NY)"},{"key":"859_CR5","doi-asserted-by":"crossref","unstructured":"Sridharan V, Mino-Kenudson M, Cleary JM et al. Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomes. Pancreatology. 2021.","DOI":"10.1016\/j.pan.2021.05.011"},{"key":"859_CR6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2214\/ajr.184.2.01840511","volume":"184","author":"S Tatli","year":"2005","unstructured":"Tatli S, Mortele KJ, Levy AD, et al. CT and MRI features of pure acinar cell carcinoma of the pancreas in adults. AJR Am J Roentgenol. 2005;184:511\u20139.","journal-title":"AJR Am J Roentgenol"},{"key":"859_CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00261-012-9868-4","volume":"38","author":"SP Raman","year":"2013","unstructured":"Raman SP, Hruban RH, Cameron JL, Wolfgang CL, Kawamoto S, Fishman EK. Acinar cell carcinoma of the pancreas: computed tomography features\u2013a study of 15 patients. Abdom Imaging. 2013;38:137\u201343.","journal-title":"Abdom Imaging"},{"key":"859_CR8","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00261-012-9970-7","volume":"38","author":"P Bhosale","year":"2013","unstructured":"Bhosale P, Balachandran A, Wang H, et al. CT imaging features of acinar cell carcinoma and its hepatic metastases. Abdom Imaging. 2013;38:1383\u201390.","journal-title":"Abdom Imaging"},{"key":"859_CR9","doi-asserted-by":"crossref","first-page":"1210064","DOI":"10.3389\/fonc.2023.1210064","volume":"13","author":"F Zhao","year":"2023","unstructured":"Zhao F, Yang D, Xu T, He J, Guo J, Li X. New treatment insights into pancreatic acinar cell carcinoma: case report and literature review. Front Oncol. 2023;13:1210064.","journal-title":"Front Oncol"},{"key":"859_CR10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1148\/radiol.11101133","volume":"259","author":"SH Yoon","year":"2011","unstructured":"Yoon SH, Lee JM, Cho JY, et al. Small (= 20\u00a0mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT<\/at. Radiology. 2011;259:442\u201352.","journal-title":"Radiology"},{"key":"859_CR11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13244-020-00861-y","volume":"11","author":"KY Elbanna","year":"2020","unstructured":"Elbanna KY, Jang HJ, Kim TK. Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review. Insights Imaging. 2020;11:58.","journal-title":"Insights Imaging"},{"key":"859_CR12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.13131184","volume":"270","author":"MM Al-Hawary","year":"2014","unstructured":"Al-Hawary MM, Francis IR, Chari ST, et al. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the American pancreatic association. Radiology. 2014;270:248\u201360.","journal-title":"Radiology"},{"key":"859_CR13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/10543406.2013.737220","volume":"23","author":"V Rousson","year":"2013","unstructured":"Rousson V, de Vet CB, Terwee LB, Mokkink, Knol DL. J Biopharm Stat. 2013;23:277\u20139.","journal-title":"J Biopharm Stat"},{"key":"859_CR14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1467-9574.1975.tb00259.x","volume":"29","author":"JRK Landis","year":"1975","unstructured":"Landis JRK, Gary G. A review of statistical methods in the analysis of data arising from observer reliability studies (Part II). Stat Neerl. 1975;29:151\u201361.","journal-title":"Stat Neerl"},{"key":"859_CR15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22:276\u201382.","journal-title":"Biochem Med (Zagreb)"},{"key":"859_CR16","volume-title":"Cancer staging manual","author":"SMBAJCC Amin","year":"2016","unstructured":"Amin SMBAJCC. Cancer staging manual. 8 ed. New York: Springer Cham; 2016.","edition":"8"},{"key":"859_CR17","first-page":"41","volume":"2","author":"S La Rosa","year":"2015","unstructured":"La Rosa S, Sessa F, Capella C. Acinar cell carcinoma of the pancreas: overview of clinicopathologic features and insights into the molecular pathology. Front Med (Lausanne). 2015;2:41.","journal-title":"Front Med (Lausanne)"},{"key":"859_CR18","first-page":"151","volume":"5","author":"B Aqel","year":"2004","unstructured":"Aqel B, Scolapio J, Nguyen J, Krishna M, Raimondo M. Recurrent pancreatitis due to a cystic pancreatic tumor: a rare presentation of acinar cell carcinoma. JOP. 2004;5:151\u20134.","journal-title":"JOP"},{"key":"859_CR19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004728-200403000-00005","volume":"28","author":"YY Chiou","year":"2004","unstructured":"Chiou YY, Chiang JH, Hwang JI, Yen CH, Tsay SH, Chang CY. Acinar cell carcinoma of the pancreas: clinical and computed tomography manifestations. J Comput Assist Tomogr. 2004;28:180\u20136.","journal-title":"J Comput Assist Tomogr"},{"key":"859_CR20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.diii.2016.07.013","volume":"97","author":"M Barral","year":"2016","unstructured":"Barral M, Faraoun SA, Fishman EK, et al. Imaging features of rare pancreatic tumors. Diagn Interv Imaging. 2016;97:1259\u201373.","journal-title":"Diagn Interv Imaging"},{"key":"859_CR21","doi-asserted-by":"crossref","unstructured":"Nakaoka K, Ohno E, Kawabe N et al. Current status of the diagnosis of Early-Stage pancreatic ductal adenocarcinoma. Diagnostics (Basel). 2023;13.","DOI":"10.3390\/diagnostics13020215"},{"key":"859_CR22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2214\/AJR.17.17862","volume":"209","author":"S Javadi","year":"2017","unstructured":"Javadi S, Menias CO, Korivi BR, et al. Pancreatic calcifications and calcified pancreatic masses: pattern recognition approach on CT. AJR Am J Roentgenol. 2017;209:77\u201387.","journal-title":"AJR Am J Roentgenol"},{"key":"859_CR23","first-page":"14846","volume":"8","author":"L Tian","year":"2015","unstructured":"Tian L, Lv XF, Dong J, et al. Clinical features and CT\/MRI findings of pancreatic acinar cell carcinoma. Int J Clin Exp Med. 2015;8:14846\u201354.","journal-title":"Int J Clin Exp Med"},{"key":"859_CR24","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1148\/rg.2020200025","volume":"40","author":"L Khanna","year":"2020","unstructured":"Khanna L, Prasad SR, Sunnapwar A, et al. Pancreatic neuroendocrine neoplasms: 2020 update on pathologic and imaging findings and classification. Radiographics. 2020;40:1240\u201362.","journal-title":"Radiographics"},{"key":"859_CR25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5334\/jbsr.1854","volume":"103","author":"KA Baek","year":"2019","unstructured":"Baek KA, Kim SS, Lee HN, Typical CT, MRI Features of Pancreatic Acinar Cell Carcinoma. Main teaching point: typical imaging features of pancreatic acinar cell carcinoma are relatively large, with a well-defined margin, exophytic growth, and heterogeneous enhancement. J Belg Soc Radiol. 2019;103:43.","journal-title":"J Belg Soc Radiol"},{"key":"859_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.diii.2019.02.003","volume":"100","author":"D Jornet","year":"2019","unstructured":"Jornet D, Soyer P, Terris B, et al. MR imaging features of pancreatic acinar cell carcinoma. Diagn Interv Imaging. 2019;100:427\u201335.","journal-title":"Diagn Interv Imaging"},{"key":"859_CR27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00000478-199209000-00001","volume":"16","author":"DS Klimstra","year":"1992","unstructured":"Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol. 1992;16:815\u201337.","journal-title":"Am J Surg Pathol"},{"key":"859_CR28","doi-asserted-by":"crossref","unstructured":"Kim H, Kim DH, Song IH et al. Survival prediction after curative resection of pancreatic ductal adenocarcinoma by Imaging-Based intratumoral necrosis. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14225671"},{"key":"859_CR29","doi-asserted-by":"crossref","unstructured":"Anderson MA, Knipp DE, Noda Y, et al. MRI-Based tumor necrosis depiction in pancreatic ductal adenocarcinoma. Volume 15. Can It Predict Tumor Aggressiveness? Cancers (Basel; 2023.","DOI":"10.3390\/cancers15082313"},{"key":"859_CR30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1148\/radiol.10100015","volume":"257","author":"JH Kim","year":"2010","unstructured":"Kim JH, Park SH, Yu ES, et al. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257:87\u201396.","journal-title":"Radiology"},{"key":"859_CR31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejso.2017.10.217","volume":"44","author":"S Crippa","year":"2018","unstructured":"Crippa S, Cirocchi R, Maisonneuve P, et al. Systematic review and meta-analysis of prognostic role of Splenic vessels infiltration in resectable pancreatic cancer. Eur J Surg Oncol. 2018;44:24\u201330.","journal-title":"Eur J Surg Oncol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00859-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-025-00859-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00859-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T18:34:39Z","timestamp":1742582079000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-025-00859-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1186\/s40644-025-00859-z","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board at the Massachusetts General Hospital, Boston, MA and informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. (retrospective).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}